Cardiff Oncology, Inc. has entered into an underwriting agreement to sell 15,384,619 shares of its common stock at $2.60 per share, aiming to raise approximately $40 million for clinical costs and general corporate purposes.
AI Assistant
CARDIFF ONCOLOGY INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.